; and (B) identify in such reporting the patient by a nonidentifiable reference and the serial number from each package of such abortion drug if available; and (2) a health care practitioner who prescribes, dispenses, or administers such abortion drug shall— (A) within 15 days of such prescribing, dispensing, or administering, report the action to the Food and Drug Administration and the Centers for Disease Control and Prevention; and (B) exclude from such reporting any individually identifiable patient information. (b) Portals The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall— (1) establish and maintain an online portal that allows health care practitioners to easily, confidentially, and securely report to the Food and Drug Administration and the Centers for Disease Control and Prevention by means of online transmission the information required by subsection (a) to be reported; and (2) establish and maintain an online portal that allows patients to easily, confidentially, and securely self-report to the Food and Drug Administration and the Centers for Disease Control and Prevention by means of online transmission any adverse events the patients have experienced that are associated with use of an abortion drug. (c) Definitions In this section: (1) The term abortion drug means any drug, substance, or combination of drugs or substances that is intended for use or that is in fact used (irrespective of how the product is labeled)— (A) to intentionally kill the unborn child of a woman known to be pregnant; or (B) to intentionally terminate the pregnancy of a woman known to be pregnant, with an intention other than— (i) to produce a live birth; (ii) to remove a dead unborn child